Recombinant Human Growth Hormone

Name: Recombinant Human Growth Hormone
Accession Number: DBCAT003261
Description: Not Available
Drugs: Drug Drug Description
Lonapegsomatropin A human growth hormone indicated in the treatment of growth failure due to inadequate endogenous growth hormone secretion.
Somatotropin A recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults.
Somatrogon A long-acting recombinant human growth hormone used as the long-term treatment of pediatric patients who have growth failure due to growth hormone deficiency.
Drugs & Drug Targets: Drug Target Type
Lonapegsomatropin 11-beta-hydroxysteroid dehydrogenase 1 enzyme
Lonapegsomatropin Growth hormone receptor target
Lonapegsomatropin Prolactin receptor target
Lonapegsomatropin Cytochrome P450 1A2 enzyme
Lonapegsomatropin Cytochrome P450 2C19 enzyme
Lonapegsomatropin ATP-dependent translocase ABCB1 transporter
Somatotropin Growth hormone receptor target
Somatotropin Prolactin receptor target
Somatotropin Cytochrome P450 1A2 enzyme
Somatotropin Cytochrome P450 2C19 enzyme
Somatotropin ATP-dependent translocase ABCB1 transporter
Somatrogon Growth hormone receptor target

Drug	Drug Description
Lonapegsomatropin	A human growth hormone indicated in the treatment of growth failure due to inadequate endogenous growth hormone secretion.
Somatotropin	A recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults.
Somatrogon	A long-acting recombinant human growth hormone used as the long-term treatment of pediatric patients who have growth failure due to growth hormone deficiency.